Proven medical device and health technology experts will show you how to improve your sales & marketing efforts, enhance your regulatory submissions, raise venture capital, and much more.


Check out the most recent interviews with world-class medical device and health technology founders and CEOs.

Go Premium

Grit and the Power of Showing Up

Interview with Venture Capitalist Anish Kaushal

Anish Kaushal, a former physician turned healthcare investor and author, shares his unconventional career journey from medicine to VC at Amplitude Ventures. He reveals vital fundraising strategies from an investor's perspective, offers practical tips for crafting pitch decks that capture attention, discusses why always being in the mode of seeking funds is so important, expands on the value of building extensive networks, and talks about the cumulative effect of small improvements. He also provides guidance on staying open and ready for career shifts in today’s fast-paced professional environment as outlined in his latest book.


The Essentials of Building the Right Foundation

Interview with Neuro42 Co-Founder Abhita Batra

Abhita Batra, co-founder and Chief Strategy Officer at Neuro42, is at the forefront of altering neurological diagnostics for good. The company recently received 510(k) clearance for its portable head and brain MRI system, which integrates MRI, AI, and robotics in one platform. Neuro42's system is a compact, easy-to-use solution for urgent care and clinical settings. In this interview, Abhita talks about her approach to building strategy at early-stage companies, the importance of a good team and thorough market analysis, and how to take a nuanced approach with regulatory bodies.


Empathy-Driven Innovation

Interview with MOLLI Surgical CEO Ananth Ravi

Under the guidance of Ananth Ravi, MOLLI Surgical has developed an award-winning, wire-free soft tissue localization technology for breast cancer surgery. Their device, MOLLI, precisely marks the location of lesions for removal during surgery and is setting a new standard for patient comfort compared to traditional methods. In this interview, Ananth unpacks his story, touching upon the benefits of being in close contact with a medical ecosystem, the importance of intuitive design, the ideal role of regulatory consultants, and the funding strategies he employs for MOLLI.


Think Big, Start Small, and Prioritize Ruthlessly

Interview with InterShunt CEO Harlee Sorkin

Harlee Sorkin’s company, InterShunt Technologies, is leading the development of a groundbreaking minimally invasive catheter designed to treat heart failure. The technique they use focuses on creating a shunt within the heart. By improving blood flow and lessening the heart's workload, it holds promise of easing heart failure symptoms, potentially setting a new standard in patient care. In this interview, Harlee delves into the nuances of leading an early-stage medtech company and covers essential topics such as development prioritization and capital fundraising. He also shares what it’s like to navigate clinical and regulatory challenges as a first-time medtech entrepreneur and how to effectively engage with stakeholders across the healthcare ecosystem.


Why Learning Fast Beats Failing Fast

Interview with Portal Instruments CEO Patrick Anquetil

Patrick Anquetil, CEO of Portal Instruments, has extensive experience in guiding bioengineering companies from their nascent stages to market success. At Portal, they are developing a novel needle-free drug delivery system. This cutting-edge technology promises to revolutionize how medications are administered, making the process less invasive, more precise, and more comfortable for patients. In this interview, Patrick talks about how he landed on Portal’s business model, how his team condenses timelines across key company functions, and why their diverse set of partners is a golden asset to the company.


Taking the Stress Out of Conception

Interview with Béa Fertility CEO Tess Cosad

We sat down with Tess Cosad, a femtech enthusiast and CEO of Béa Fertility. Founded in 2020, Béa offers innovative, hormone-free, accessible, at-home fertility treatments and ovulation tracking as an alternative to traditional clinic-based offerings. Their flagship product simplifies the fertility journey thanks to its user-friendly design. In this interview, Tess delves into the challenges and triumphs of launching a consumer-facing product, the importance of a solid design team, how to be comfortable making decisions with imperfect information, and the lessons she learned about being a CEO while raising funds.


Get exclusive benefits like full access to the entire archive of Medsider interviews and every Medsider Mentors volume.

Go Premium

Building a Startup in a Collaborative Ecosystem

Interview with Noa Therapeutics CEO Carla Spina

In this episode, we sit down with Carla Spina, the pioneering force behind Noa Therapeutics. Carla and her team are developing treatments for inflammatory skin diseases with their innovative multimodal small-molecule therapies. Carla shares her invaluable experiences on the importance of engaging actively with the startup ecosystem and staying connected with those who are shaping the field. We talk about how building a company is a collaborative venture that requires a strong network of entrepreneurs, investors, and industry experts, and the significance of authentic interaction when reaching out to a variety of potential stakeholders.


Balancing Innovation with Practical Outsourcing

Interview with Spark Biomedical CEO Daniel Powell

Daniel Powel is the CEO of Spark Biomedical, developers of the Sparrow Ascent, a drug-free wearable device to combat opioid withdrawal symptoms. In this interview, Daniel shares key insights from his journey: the importance of testing ideas and creating a MVP, diversifying funding sources, and how to make informed regulatory decisions.


Shaping the Future of Alzheimer’s Care

Interview with Sinaptica CEO Ken Mariash

Ken Mariash is a leading figure in the neuromodulation space and the CEO of Sinaptica Therapeutics, where his team is developing groundbreaking treatments for Alzheimer's disease. Their device delivers non-invasive neuromodulation therapy to key networks of the brain, and has shown unprecedented improvement in treating this debilitating disease. In our interview, Ken shares his time-tested wisdom, covering a range of topics from kick-starting a venture and how to approach M&A transactions, to mastering commercialization and best practices for engaging with investors.


Your Network is Your Net Worth

Interview with NeuroOne CEO Dave Rosa

Dave Rosa, President and CEO of NeuroOne, is a seasoned leader in the medical device industry with over thirty years of experience. NeuroOne is developing high-definition, minimally invasive neurology devices utilizing its unique thin-film electrode technology. In this interview, Dave discusses critical strategies to secure initial capital even before early development and regulatory milestones are achieved, how to leverage networks to connect with potential investors; and the importance of assembling a supportive and experienced team, including board members.


Pioneering AI in Patient Diagnosis

Interview with Digital Diagnostics CEO John Bertrand

John Bertrand is the CEO of Digital Diagnostics, a company that is pioneering AI healthcare systems. Its flagship product, LumineticsCore, is an algorithm that autonomously diagnoses patients with diabetic retinopathy. In our interview, John shares his insights on aligning products with real-world needs, the importance of stakeholder engagement for adoption and long-term success, and strategies for navigating the extended sales cycles in healthcare technology.


Collaborating for Clinical Credibility

Interview with Strados Labs CEO Nick Delmonico

In this interview Nick Delmonico, the CEO of Strados Labs, a company developing a wearable stethoscope to remotely capture lung sounds, discusses how Strados validated its technology through others' research and how starting with a clear understanding of the problem, rather than jumping straight to offering solutions, created significant opportunities for his company. Nick also emphasizes why interpersonal skills and active listening are crucial to success in medtech, and shares strategies for non-dilutive funding as a way to alleviate initial capital constraints while building credibility at the same time.


How to Secure Widespread Adoption of Novel Technology

Interview with Magnolia Medical CEO Greg Bullington

Greg Bullington, co-founder and CEO of Magnolia Medical, offers firsthand insights on establishing a new standard of care with Steripath, a device designed to enhance sepsis testing accuracy by reducing blood culture contamination. In this interview, he talks about the pivotal role of robust clinical data, why Magnolia is still running studies even after proving their device’s efficacy, and how to use the results to successfully convince different entities such as FDA and other government bodies in public health.


How to Get Users to Fall in Love with Your Product

Interview with SafKan Health CEO Sahil Diwan

Sahil Diwan brings a youthful, creative energy to medtech entrepreneurship. His company, SafKan Health, is automating ear wax removal, easing the burden on both patients and physicians. In this interview, we talk about consumer-driven medtech, the power of design, garnering experience from real-world data, focusing on building the business before fundraising, and how OtoSet went viral on social media.